INTRODUCTION
Diabetes has evolved into an epidemic in India. The estimated number of patients with diabetes in India was 62.4 million in 2011 which is projected to rise to a staggering 101.2 million by 2030. 1, 2 Diabetes mellitus, a heterogeneous group of metabolic disorders is characterized by hyper-glycaemia resulting from defect in insulin secretion, insulin action or both. The lack of effective insulin action leads to alteration in carbohydrate, fat and protein metabolism. 3 Insulin resistance, relative insulin deficiency and obesity are found to be associated with hypertriglyceridemia, low serum HDL cholesterol and occasionally high serum LDL cholesterol in type 2 diabetes mellitus. Dyslipidemia in diabetes commonly manifests as raised low-density lipoprotein cholesterol (LDL-C), decreased high-density lipoprotein cholesterol (HDL-C) levels, or elevated triglyceride (TG) levels. 4 Hypertriglyceridemia is an independent risk factor for coronary heart disease. 5 It is well-established that dyslipidemia is a major risk factor for macrovascular complications in patients of type-2 diabetes mellitus and affects 10%-73% of this population. 6 The Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III or ATP  III) 7 has reported Diabetes mellitus as the equivalent of coronary heart disease (CHD), elevating it to the highest risk category.
India has diverse lifestyle pattern and ethnic variations, thus epidemiological profile of diabetes mellitus may be different in different geographical areas. Ethnic Punjabi people are presumed to have high prevalence of coronary artery disease (CAD) risk factors: obesity, metabolic syndrome, diabetes, hypertension, dyslipidemia because of traditional Punjabi food and less physically active lifestyle. There are very few data available for prevalence of dyslipidemia in diabetes from Indian continent, which are mainly from South Indian population and few from North Indian population. 8 The present study aims to bridge the gap by studying the pattern of dyslipidemia in patients of type 2 diabetes mellitus of Punjab.
METHODS
This cross sectional study was carried on the patients attending the Medicine OPD of Punjab Institute of Medical Sciences, Jalandhar during 6 months period of March, 2015 to August, 2015. The patients of type 2 diabetes mellitus visiting consecutively in the Medicine OPD were considered for this study. The patients included in the study were already diagnosed with diabetes mellitus type 2 taking treatment and newly diagnosed diabetes mellitus type 2 patients. The patients of type 1 diabetes mellitus were not considered for this study. The patients who were also suffering from coronary artery disease (CAD) or had history of cerebrovascular accident (CVA) or were diagnosed as having CAD or CVA after enrolment and those patients already taking statins or other drugs for lipid lowering were excluded from this study. And those diabetic patients suffering from metabolic disorder or chronic systemic diseases were also excluded from the study. In those patients included in the study, detailed history was taken and clinical examination was done. The demographic parameters (age, sex, urban or rural) of the patients were recorded and their weight and height were recorded using standard methods. Fasting blood sample of the patients after at least 8 hours overnight fast was taken to measure serum lipid profile parameters of total cholesterol (TC), triglycerides (TG), low density lipid cholesterol (LDL-C) and high density lipid cholesterol (HDL-C). The cut-off normal values for individual lipid levels were taken as per guidelines of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 7 The term dyslipidemia refers to two or more abnormal lipid levels. The body mass index (BMI) was calculated by the Quetelet Index, BMI = Weight (Kg) / Height (m) 2 from weight and height measurements. 9 The data of the individual patients was entered in the Microsoft Excel sheet and was analysed statistically using SPSS version 20 software. 
RESULTS

DISCUSSION
Patients with diabetes mellitus have a 2 to 4 fold increased risk of cardiovascular, peripheral vascular and cerebrovascular disease, which are the leading causes of morbidity and mortality in this population. Diabetes is considered a coronary heart disease (CHD) -risk equivalent and it is frequently associated with various other cardiovascular (CV) risk factors. It is well-established that dyslipidemia is a major risk factor for macrovascular complications in patients with type-2 diabetes mellitus and affects 10%-73% of this population.
6,10 Approximately 80% of deaths in patients with diabetes are attributable to cardiovascular disease (CVD). Asian Indians have higher risk of CHD than whites.
11 Dyslipidemia in diabetes commonly manifests as raised low-density lipoprotein cholesterol (LDL-C), decreased high-density lipoprotein cholesterol (HDL-C) levels, or elevated triglyceride (TG) levels. 4 Furthermore, data from the United Kingdom Prospective Diabetes Study suggest that both decreased HDL-C and elevated LDL-C predict CHD in diabetes. 12 The present study shows very high prevalence of dyslipidaemia (81.8%) in the patients of type 2 diabetes mellitus.
Though the burden of diabetes and dyslipidemia in India is mainly contributed by urban population, the increasing trend of diabetes and even dyslipidemia is observed in rural population too, because of urbanization and changing lifestyle and food habits. In this study, dyslipidemia is found more in rural patients (84.6%) compared to urban patients (81.1%). Diabetic dyslipidaemia is assumed to be due to lavish lifestyle of fat and sugar rich food and lesser physical exercise. The high prevalence of dyslipidaemia in Punjabi diabetic patients might be contributing towards the rising prevalence of CAD in Punjab. More so, both male and female patients had dyslipidaemia in almost similar rates (male: 84.7% and female: 78.9%).
Considering the age of the patients studied, one frightening finding is that the young patients (<45 years age group) had similar prevalence of dyslipidaemia (82.6%) as patients of older groups (82.9% in 45 -60 years and 83.7% in >60 years age groups). Considering BMI of the patients, dyslipidaemia is observed in 84.1% obese subjects and the non-obese patients also had the high prevalence (76.6%) of deranged lipids.
The recent focus on the pattern of dyslipidaemia in diabetes mellitus type 2 shows elevated triglycerides, elevated LDL and low HDL cholesterol. 13 Our study reveals that all lipids had abnormal mean levels as shown in Table 2 ; hypertriglyceridemia and high levels of LDL in 57.2% and 59.3% patients and low levels of serum HDL in 34.4% patients. Rakesh et al have also reported high LDL and low HDL in their study. 14 In this study, most of the patients had mixed dyslipidaemia with more than one lipid abnormality. The mixed dyslipidaemia observed most commonly in our study was high LDL levels and hypertriglyceridemia (38.2%) which is different from the western studies. The serum LDL levels are not found very high in these studies. 15, 16 These two abnormalities i.e. hypertriglyceridemia and raised levels of LDL cholesterol are strong risk factors for CAD in patients of type 2 diabetes mellitus. In our study, two other types of mixed dyslipidaemia were observed: hypercholesterolemia with high LDL levels and hypercholesterolemia with hypertriglyceridemia. Smith S et al also found hypercholesterolemia (mean±SD of total cholesterol 299.36±13.46) in their study done in Allahabad, India. 17 All the lipids were deranged in the 11.6% of the diabetic patients studied. Rani HS et al evaluated the risk factors for coronary heart disease in diabetes mellitus patients and found that, TC, VLDL, LDLs, TGs were high and the levels of HDLs were low compared to controls. 18 Dyslipidemia is a well-recognized and modifiable risk factor that should be identified early to institute aggressive cardiovascular preventive management. 19 So, the complete lipid profile of diabetic patients should be analysed instead of going for individual lipid fraction levels and the lipid lowering treatment should be started as early as possible.
